Publication Name	World Journal of Medical Genetics
Manuscript ID	16286
Country	United States

Received	2015-01-08 08:23
Peer-Review Started	2015-01-08 20:43
To Make the First Decision	2015-03-06 10:32
Return for Revision	2015-03-11 11:25
Revised	2015-04-08 05:40
Second Decision	2015-05-07 09:49
Accepted by Journal Editor-in-Chief	2015-05-07 17:46
Accepted by Company Editor-in-Chief	2015-05-18 16:59
Articles in Press	2015-05-18 16:59
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-08-18 15:41
Publish the Manuscript Online	2015-08-26 12:03

ISSN	2220-3184 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Biotechnology & Applied Microbiology
Manuscript Type	Editorial
Article Title	Adeno-associated virus vectors for human gene therapy
Manuscript Source	Invited Manuscript
All Author List	Haifeng Chen
Funding Agency and Grant Number
Corresponding Author	Haifeng Chen, PhD, CEO of Virovek Incorporation, 3521 Investment Blvd., Suite 1, Hayward, CA 94545, United States. haifengchen05@yahoo.com
Key Words	Adeno-associated virus; Adeno-associated virus production and purification; Clinical trials; Gene therapy; Baculovirus
Core Tip	Adeno-associated virus (AAV) has become the first gene therapy drug approved by the Western world and spurred huge excitement in the gene therapy field. The gene therapy community is forging ahead with cautious optimism despite some challenges down the road. A battery of more than 100 AAV serotypes and variants are available and AAV production and purification technologies have become well established. Several clinical trials with AAV vectors have yielded exciting results. This paper will give you the information needed to understand the current development of the gene therapy field with AAV vectors.
Publish Date	2015-08-26 12:03
Citation	Chen H. Adeno-associated virus vectors for human gene therapy. World J Med Genet 2015; 5(3): 28-45
URL	http://www.wjgnet.com/2220-3184/full/v5/i3/28.htm
DOI	http://dx.doi.org/10.5496/wjmg.v5.i3.28

Full Article (PDF)	WJMG-5-28.pdf
Full Article (Word)	WJMG-5-28.doc
Manuscript File	16286-Review.docx
Answering Reviewers	16286-Answering reviewers.pdf
Audio Core Tip	16286-Audio core tip.wma
Conflict-of-Interest Disclosure Form	16286-Conflict-of-interest statement.pdf
Copyright License Agreement	16286-Copyright assignment.pdf
Peer-review Report	16286-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	16286-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	16286-Scientific misconduct check.pdf
Scientific Editor Work List	16286-Scientific editor work list.pdf